Guidance

Choosing between oral vancomycin options

18 May 2021Local decision makers should choose between the options for giving vancomycin orally. Licensing status and other factors affect decision making.

Guidance

Cautions and contraindications

Using antidepressants for depression in people with epilepsy

14 May 2021Antidepressant use requires special consideration in people with epilepsy. Treating stable depression is covered.

Repeat supply or administration of medicines under PGD

26 April 2021The below article details the position regarding use of a PGD to make repeat supplies/repeated administrations of a medicine.

Extension of expiry date of a Patient Group Direction

26 April 2021This Q&A advises on the extension to the expiry date of a PGD where a full review and re-authorisation has not taken place.

Dosing and monitoring for treatment of Vitamin D deficiency in pregnancy

24 March 2021Effective treatment of vitamin D deficiency in pregnancy requires consideration of treatment regimens, monitoring, and preferred forms of vitamin D.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021This article reflects MHRA guidance on the use of PGDs for medications which have risk minimisation measures (RMM).

Good governance guidance when handling multiple COVID-19 vaccines

2 March 2021Practice points to ensure good governance when planning or designing vaccination services where multiple vaccines are used.

Safe practice for handling multiple COVID-19 vaccines

2 March 2021A number of COVID-19 vaccines are available, all with different handling and dosing requirements; sites need to plan to reduce the risk of errors

Governance of Medical Gas Provision: key publications

13 January 2021Signposts to key publications from the Department of Health and Health Facilities Scotland

SPS - Specialist Pharmacy Service

NHS